AIBN was established with the specific aim of combining research excellence with an industry focus.

The commercial objectives of the Institute are to:

  • Produce innovations assisting in the growth of industries;
  • Develop new products, processes and technologies; and
  • To play a major role in developing the Australian nanotechnology and biotechnology industries, through establishing new opportunities, obtaining the support of the industry sector and interfacing with industrial collaborators.

AIBN has worked to develop and promote:

  • A culture of commercialisation within the Institute;
  • Strategies to support the Institute’s commercialisation and industry engagement;
  • The Institute’s R&D capabilities and infrastructure to industry; and
  • A suite of quality patent assets relevant to industry and market need.

 

  • AIBN Industrial Affiliates Program

    The Institute is proud of its ability to develop new solutions to the technological issues confronting industry, and has designed the Industrial Affiliates Program to benefit industry and AIBN.

    While the extent of member benefits varies according to the level of membership, all members obtain access to exclusive networking events; invitations to seminars, symposia and conferences organised by AIBN; the opportunity to nominate suitably qualified peoples as Academic Adjuncts of The University of Queensland; and access to AIBN public disclosures. IAP members receive acknowledgement and recognition of their membership in AIBN’s Annual Report and on the membership board in the AIBN foyer.

    Premier members are also acknowledged at selected AIBN functions and events. Premier members and members receive a customised IAP access package. It includes an initial consultation with relevant AIBN personnel, along with substantial discounts on fees charged for subsequent consulting advice from AIBN personnel and access fees for AIBN-managed facilities.
     

    Structure of the Program

    The Industrial Affiliates Program is designed to cater to small, medium and large companies.

    The Program offers three levels of membership:

    Starting at AUD$1500, these levels are designed to suit the individual needs and objectives of small, medium and large companies.

    Premier member

    This is the premium level of engagement with the AIBN. Companies receive the greatest level of flexibility when interacting with Institute researchers. This translates as more opportunities to benefit from the ideas, know-how and capabilities at AIBN.

    This level of engagement is most suitable for an organisation looking to aggressively drive its research and development activities in areas where access to state-of-the-art facilities and know-how is critical to its mission.

    Member

    Members are offered a high level of engagement with AIBN and opportunities to interact directly with groups and facilities within AIBN. This level of engagement is most suitable for a small to medium enterprise seeking to augment its in-house activities with access to know-how and facilities.

    Associate member

    Associate member is an entry level membership designed to give companies an introduction to the breadth and depth of AIBN. Associate members have opportunities to interact with AIBN researchers and explore the range of services and capabilities offered.

    Associate membership is available to select non-research organisations, such as service providers operating in areas relevant to AIBN, whose primary interest is access to IAP networking functions.

    To further discuss the AIBN Industrial Affiliates Program please contact:

    Dr Ian Nisbet
    Industry Fellow
    T: + 61 431 709 121
    F: + 61 7 3346 3973
    Email: i.nisbet@uq.edu.au  

    Dr Aoife Cullen
    Business Development and Industry Engagement Manager
    T: + 61 7 3346 3945
    F: + 61 7 3346 3973
    Email: a.cullen@uq.edu.au

    The Industrial Affiliates Program is designed to cater to small, medium and large companies.
  • Continuing Professional Development

    Click below for information on Continuing Professional Development courses held at AIBN.

    AIBN offers Continuing Professional Development courses.
  • Industrial relevance

    AIBN is rich with know-how and intellectual property that has the potential to alleviate current human health and environmental problems. AIBN has extensive research capabilities combined with a unique and comprehensive suite of facilities available to industrial research communities in Australia.

    AIBN has extensive research capabilities combined with a unique and comprehensive suite of facilities available to industrial research communities in Australia.
  • How we work with industry

    The AIBN’s Innovation and Commercial Development (I&CD) team focuses on the intellectual property (IP) management and commercialisation of the Institute’s research and development activities, as well as fostering industry-led collaborations and contract research.

    The AIBN has a strong commercial focus. To support and rapidly build the Institute’s commercialisation activity, AIBN has a strategic relationship with UniQuest Pty Limited providing access to commercialisation expertise, processes and resources. UniQuest is recognised as an Australian leader in research commercialisation and is the main commercialisation company of The University of Queensland.

    I&CD Strategy

    The commercial objective of the Institute is to produce innovations assisting in the growth of industries; the development of new products, processes and technologies; and play a major role in developing the Australian nanotechnology and biotechnology industries. This objective will be met through a dual commercialisation strategy.

    The ‘inside-out’ strategy provides for the development of AIBN’s IP through market-led R&D, funded from public and private sources as appropriate and commercialised via a license agreement or forming a start-up company to further develop the technology into a product.

    In contrast the ‘outside-in’ strategy aims to capitalise on AIBN’s capabilities, infrastructure and intellectual capital by working closely for or with industry.

    I&CD engages with key figures in the bioengineering and nanotechnology industries, to determine their various needs, which often results in commercial discussions leading to consultancy and collaborative research arrangements, contract research and license agreements.

    AIBNís Innovation and Commercial Development (I&CD) team conducts key commercialisation activities.
  • I&CD contacts

    Dr Aoife Cullen
    Business Development and Industry Engagement Manager
    M: +61 (0) 417 644 056
    a.cullen@uq.edu.au

    Manager, Innovation and Commercial Development
    T: +61 7 334 63960
    F: +61 7 336 54433
    M: +61 (0) 409 591 168

    Dr Ian Nisbet
    Industry Fellow
    M: +61 431 709 121
    F: +61 7 3365 4435
    E: i.nisbet@uq.edu.au

    Dr Raisa Monteiro
    Research Partnerships Manager
    T: +61 7 3346 4526
    F: +61 7 3365 4435
    E: r.monteiro@uq.edu.au

    Contact AIBN's Innovation and Commercial Development team.
Go to top